טוען...
Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans
Candida albicans, one of the pathogenic Candida species, causes high mortality rate in immunocompromised and high-risk surgical patients. In the last decade, only one new class of antifungal drug echinocandin was applied. The increased therapy failures, such as the one caused by multi-drug resistanc...
שמור ב:
| הוצא לאור ב: | Virulence |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4601232/ https://ncbi.nlm.nih.gov/pubmed/26048362 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21505594.2015.1039885 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|